Literature DB >> 8814453

Mapping of chromosomal gains and losses in primitive neuroectodermal tumors by comparative genomic hybridization.

B R Schütz1, W Scheurlen, J Krauss, S du Manoir, S Joos, M Bentz, P Lichter.   

Abstract

A series of 18 primitive neuroectodermal tumors (PNETs), the most common malignant central nervous system tumors of childhood, were analyzed with the recently developed approach of comparative genomic hybridization (CGH). In five cases, in which only small amounts of DNA were available, universal polymerase chain reaction was successfully applied to generate adequate probe material. In 15 tumors, chromosomal imbalances were elicited, most frequently involving chromosome 17 (loss of 17p and gain of 17q). Further recurrent imbalances included gains of the distal regions of 4p, 5p, 5q, 7q, 8q, and 9p. High-level amplifications were found on 2p24 (one case) and 8q24 (three cases), suggesting involvement of the protooncogenes MYCN and MYC, respectively. In one of these cases, Southern blot analysis could be performed, proving high-copy-number amplification of MYC. Interestingly, none of the three patients with high-copy-number amplifications of MYC responded to therapy.

Entities:  

Mesh:

Year:  1996        PMID: 8814453     DOI: 10.1002/(SICI)1098-2264(199607)16:3<196::AID-GCC7>3.0.CO;2-U

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  12 in total

Review 1.  DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies.

Authors:  S Knuutila; A M Björkqvist; K Autio; M Tarkkanen; M Wolf; O Monni; J Szymanska; M L Larramendy; J Tapper; H Pere; W El-Rifai; S Hemmer; V M Wasenius; V Vidgren; Y Zhu
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

2.  Molecular analysis of medulloblastomas occurring simultaneously in monozygotic twins.

Authors:  W Scheurlen; N Sörensen; W Roggendorf; J Kühl
Journal:  Eur J Pediatr       Date:  1996-10       Impact factor: 3.183

3.  Imbalances of chromosome 17 in medulloblastomas determined by comparative genomic hybridisation and fluorescence in situ hybridisation.

Authors:  J Nicholson; C Wickramasinghe; F Ross; J Crolla; D Ellison
Journal:  Mol Pathol       Date:  2000-12

Review 4.  Molecular pathogenesis of childhood brain tumors.

Authors:  Torsten Pietsch; Michael D Taylor; James T Rutka
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

5.  Cytogenetic and histopathologic studies of congenital supratentorial primitive neuroectodermal tumors: a case report.

Authors:  H J Girschick; R Klein; W G Scheurlen; J Kühl
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

Review 6.  Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.

Authors:  Judith M de Bont; Roger J Packer; Erna M Michiels; Monique L den Boer; Rob Pieters
Journal:  Neuro Oncol       Date:  2008-08-01       Impact factor: 12.300

7.  From amplification to gene in thyroid cancer: a high-resolution mapped bacterial-artificial-chromosome resource for cancer chromosome aberrations guides gene discovery after comparative genome hybridization.

Authors:  X Chen; J A Knauf; R Gonsky; M Wang; E H Lai; S Chissoe; J A Fagin; J R Korenberg
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

8.  Adult primitive neuroectodermal tumors: the prognostic value of supratentorial location.

Authors:  Rikesh Gandhi; Ranjith Babu; Thomas J Cummings; Cory Adamson
Journal:  J Neurooncol       Date:  2013-05-30       Impact factor: 4.130

9.  Promoter methylation pattern of caspase-8, P16INK4A, MGMT, TIMP-3, and E-cadherin in medulloblastoma.

Authors:  Martin Ebinger; Leonore Senf; Olga Wachowski; Wolfram Scheurlen
Journal:  Pathol Oncol Res       Date:  2004-03-18       Impact factor: 3.201

10.  Comparative genomic hybridization and histological variation in primitive neuroectodermal tumours.

Authors:  J C Nicholson; F M Ross; J A Kohler; D W Ellison
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.